Phase I-II study of ADXS31-142 alone and in combination with pembrolizumab in patients with previously treated metastatic castration-resistant prostate cancer (mCRPC): the KEYNOTE-046 trial
Crossref DOI link: https://doi.org/10.1186/2051-1426-3-S2-P153
Published Online: 2015-11-04
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Haas, Naomi B
Stein, Mark N
Tutrone, Ronald
Perini, Rodolfo
Denker, Andrew
Mauro, David
Fong, Lawrence
Article History
First Online: 4 November 2015